All News

Here’s a sneak peek at what’s inside our Fall 2019 issue.

During the 2019 Prostate Cancer Consensus Conference, one expert discussed three clinical trials and the future of genetic testing in patients with the disease.

Looking back on Day One in the chemotherapy journey.

Phase 3 clinical trial results showed that certain mouthwashes benefit and reduce pain in patients with oral mucositis.

Is there anything I would tell my younger self about any risks for cancer? What about now: what can I suggest to my sister? What do I need to tell my children about their risks for cancer?

Forty-eight percent of those surveyed by The Pink Fund said the cost of transportation was a barrier to receiving treatment and 60% missed an appointment or were late to one because of transportation issues.

Facing those drawn-out days between a breast cancer diagnosis and mastectomy surgery.

Here is a list of the recent trial initiations that occurred within the cancer space in October.

CURE® asked its readers for their thoughts on “Pinktober,” which ran the gamut of emotions.

A single question acknowledging someone else's experience can lift the heavy feeling of cancer isolation.

Using artificial intelligence to analyze huge stores of information known as big data boosts the effectiveness of cancer diagnosis and treatment.

A two-time cancer survivor learns more about pancreatic cysts and discusses the value and cautions of genetic testing.

Radiation and chemotherapy increase a patient’s risk of developing the side effect known as oral mucositis, but certain actions can be taken to improve quality of life.

From the Food and Drug Administration’s call to action over breast implant-associated illness and lymphoma to a four-time survivor’s college football debut, here’s what is making headlines in the cancer space this week.

Faith may influence a breast cancer recovery by helping a person gain a deeper understanding of their life’s meaning and purpose.

The Food and Drug Administration has approved Zejula for patients with advanced ovarian, fallopian tube, or primary peritoneal cancer that have been treated with three or more prior chemotherapy regimens and whose cancer is associated with homologous recombination deficiency-positive status.

Sometimes starting a new chapter in life can be good for cancer survivors.

Patients with recurrent, metastatic or persistent cervical cancer may benefit from the TIL immunotherapy LN-145.

We've got a sneak peek at what’s inside CURE®'s 2019 Genitourinary Cancers special issue.

Patients with recurrent or metastatic cervical cancer were treated with combination Opdivo and Yervoy in the CheckMate-358 clinical trial.

"They say once you hear the word cancer, you retain maybe 40 percent of the information that follows, but the words 'ovarian cancer' got through alright."

The Metastatic Breast Cancer Alliance (MBCA) launched a campaign to bring awareness of clinical trials to more individuals and encourage them to speak with their health care teams about them.

Dealing with any type of illness after cancer can be a frightening experience.

Save the date! We invite you to join CURE for our next monthly #CureConnect Tweet Chat on Thursday, October 31, at 1 p.m. EST, when we plan on discussing coping with cancer.

Recent changes to the National Comprehensive Cancer Network (NCCN) guidelines around prostate cancer have updated the indications for genetic testing and have opened up a broader discussion on how it can be used to improve prostate cancer detection and treatment, according to Dr. James Mohler.

The same properties that make certain cancers hard to treat may also promote their death by ferroptosis, scientists at the Sloan Kettering Institute have found.

It isn’t easy living with stage 4 breast cancer when people want to hear uplifting stories about survivors.

From a chemotherapy drug shortage to Eddie Van Halen revealing a cancer diagnosis, here’s what is making headlines in the cancer space this week.